Valuation: Isodiol International Inc.

Market Cap 3.91M 2.8M 2.5M 2.29M 2.09M 265M 3.99M 27.39M 11.04M 140M 10.51M 10.28M 442M P/E 2018
-4.94x
P/E 2019 -0.37x
Enterprise Value 9.13M 6.54M 5.84M 5.36M 4.87M 619M 9.32M 63.96M 25.78M 327M 24.53M 24.01M 1.03B EV / Sales 2018
12.6x
EV / Sales 2019 2.48x
Free-Float
100%
Yield 2018 *
-
Yield 2019 -
1 week 0
Extreme 1.0E-6
0
1 month 0
Extreme 1.0E-6
0
Current year 0
Extreme 1.0E-6
0
1 year 0
Extreme 1.0E-6
0
3 years 0
Extreme 1.0E-6
0
5 years 0
Extreme 1.0E-6
0
10 years 0
Extreme 1.0E-6
16.9
Manager TitleAgeSince
Chief Executive Officer - 2017-05-23
Corporate Officer/Principal - 2018-08-29
Director TitleAgeSince
Director/Board Member - 2017-05-23
Director/Board Member - 2018-08-29
Director/Board Member - 2018-11-20
Change 5-day change 1-year change 3-year change Capi.($)
-.--%-.--% - - 128
-0.46%+10.31%+57.38%+143.15% 1,263B
-0.97%+1.60%+45.26%+80.09% 658B
-2.05%+0.73%+36.27%+101.62% 521B
-1.54%+1.61%+53.42%+67.10% 391B
-0.78%+5.51%+79.85%+44.25% 369B
-1.69%+2.75%+32.49%+54.35% 307B
-0.72%+8.08%+11.15%+34.09% 290B
-0.12%+4.68%+57.09%+74.59% 252B
-0.21%+7.34%+39.56%+109.69% 212B
Average -0.65%+5.31%+45.83%+78.77% 426.19B
Weighted average by Cap. -0.76%+6.60%+48.67%+93.27%

Financials

2018 2019
Net sales 19.14M 13.7M 12.23M 11.22M 10.21M 1.3B 19.52M 134M 54.02M 684M 51.4M 50.31M 2.16B 22.25M 15.92M 14.22M 13.05M 11.87M 1.51B 22.69M 156M 62.81M 796M 59.76M 58.49M 2.51B
Net income -36.02M -25.78M -23.02M -21.12M -19.21M -2.44B -36.74M -252M -102M -1.29B -96.75M -94.69M -4.07B -126M -90.11M -80.45M -73.83M -67.16M -8.53B -128M -882M -355M -4.5B -338M -331M -14.22B
Net Debt -15.55M -11.13M -9.94M -9.12M -8.29M -1.05B -15.86M -109M -43.9M -556M -41.77M -40.88M -1.76B 5.22M 3.74M 3.34M 3.06M 2.79M 354M 5.33M 36.57M 14.74M 187M 14.03M 13.73M 590M
Logo Isodiol International Inc.
Isodiol International Inc. is a Canada-based company, which is engaged in product development, sales, marketing, and distribution of hemp-based consumer packaged goods (CPG) and solutions. The Company supplies industrial hemp derivatives for medicinal formulations in the nutraceutical, cosmetic, and pharmaceutical markets. It grows and harvests hemp on an industrial scale, then processes and extracts cannabidiol (CBD) for distribution. It has commercialized naturally isolated CBD, including micro-encapsulations, and nanotechnology for consumables and topical skin care products. The Company's ready to label program offers a range of CBD products ready to be added or developed for various brands. The Company is focused on developing over-the-counter and pharmaceutical drugs and international expansion into Latin America, Asia, and Europe.
Employees
-
Date Price Change Volume
26-10-30 US$0.000001 -.--% 2,743
26-10-29 US$0.000001 -.--% 1,500
  1. Stock Market
  2. Stocks
  3. ISOLF Stock